Editor's key points † The Bohr effect underpins why hypercapnia favours unloading of oxygen at the tissue level. † Permissive hypercapnia-enhanced tissue oxygenation could reduce surgical site infection. † This study found that mild hypercapnia could possibly reduce the risk of surgical site infection but such an effect appears small. † Obesity is associated with higher rates of surgical site infection.
Background
Surgical site infections (SSIs) are common and serious complications of anaethesia and surgery. 1 -3 Even with the best sterile technique, surgical wounds may become infected. Oxidative killing by neutrophils-the primary defence against pathogens 4 5 -requires molecular oxygen and critically depends on local tissue oxygen partial pressure. 6 7 Consequently, SSI is inversely related to tissue oxygenation during and for a few hours after surgery. 8 -10 Tissue oxygenation, reflecting local perfusion and arterial oxygen partial pressure (Pa O 2 ), is enhanced by cardiac output, 11 pain control, 12 supplemental fluid, 13 management of carbon dioxide, 14 15 and epidural anaesthesia. 16 Mild hypercapnia also increases subcutaneous 11 17 and splanchnic 14 18 oxygenation and perfusion, primarily by increasing cardiac output and oxygen availability. 19 20 Hypercapnia also appears to be anti-inflammatory when applied during acute lung injury models in animals. 21 22 We therefore tested the hypothesis that mild hypercapnia [end-tidal partial pressure (PE ′ CO 2 ) of 50 vs 35 mm Hg] during general anaethesia reduces the incidence of SSI (followed up for 30 days) in patients undergoing colon resection.
Methods
With institutional review board approval of participating centres and written consent, we enrolled adults 18-80 yr old who were undergoing elective colon resection expected to last between 2 and 6 h. Exclusion criteria included chemotherapy in the 6 months preceding surgery, anticipated secondary wound closure, fever (≥388C) or infection at admission, severe COPD [i.e. forced expiratory volume 1 (FEV 1 )/forced vital capacity ,70%; FEV 1 ,50% predicted, with or without chronic symptoms], unstable angina pectoris, hypertensive cardiomyopathy, congestive heart failure (according to the Modified Framingham Criteria), myocardial infarction within 6 months, known bowel obstruction (confirmed or clinical suspicion of obstruction defined by the primary surgeon), and ASA Physical Status ≥IV.
Mild hypercapnia increases subcutaneous tissue PO 2 by 26-32 mm Hg in patients undergoing major abdominal surgery compared with normocapnia at an FI O 2 of 0.40. 14 15 Previous work suggests that using the more conservative 26 mm Hg increase in tissue oxygen partial pressure would reduce infection risk by a third, from 8.2% in normocapnic patients to 5.4% in those assigned to hypercapnia. 8 A total of 1994 patients would therefore provide 80% power to identify a statistically significant difference between the groups at a one-tailed alpha level of 0.05; we therefore planned to study 2000 patients with an interim analysis at 1000 patients.
Protocol
Patients were given electrolyte bowel preparation without antibiotics the night before surgery. According to surgical routine, cefuroxime (1.5 g i.v.) and metronidazole (0.5 g i.v.), cefotetan (2 g i.v.), or ertapenem (1 g i.v.) were given during anaesthetic induction. Propofol (2-4 mg kg 21 ) were used for induction of anaesthesia and muscle relaxation provided by rocuronium (0.6 mg kg 21 ) or vecuronium (0.1 mg kg 21 ); anaesthesia subsequently was maintained with desflurane or sevoflurane, fentanyl, and neuromuscular blocking drugs as clinically required. Postoperative epidural analgesia was permitted.
After induction of anaesthesia, patients were assigned to normocapnia or hypercapnia, stratified by centre. Assignments were based on computer-generated randomizations that were kept in sealed, sequentially numbered envelopes until used. Envelopes were opened in the operating theatre just before the start of surgery. Subjects assigned to normocapnia were maintained at a target intraoperative PE ′ CO 2 of 35 mm Hg; the target in patients assigned to hypercapnia was 50 mm Hg. In hypercapnia patients, CO 2 absorbent was removed from the partial-rebreathing circle system. Tidal volume was set at 8-10 ml kg 21 with a respiratory rate of 8-10 bpm , and fresh gas flow was adjusted to maintain PE ′ CO 2 at 50 mm Hg. Patients assigned to normocapnia were similarly ventilated, but with CO 2 absorbent in the partial-rebreathing circle system as usual. Inspired oxygen concentration was controlled at 80% in the initial 620 patients because of the reported beneficial effects of supplemental oxygen. 1 The final 585 patients were assigned to 30 or 80% intraoperative oxygen and to receive 4 mg i.v. dexamethasone or placebo in a factorial approach. During the study enrolment period, new evidence from another randomized controlled trial reported negative results challenging the potential benefits of supplemental oxygen. 23 Therefore, we decided to randomize inspired oxygen concentrations to 30 or 80%. Corticosteroids impair innate immune responses and, as a result, may impair healing. As might be expected, chronic preoperative corticosteroid use increases wound infection risk, 24 25 but there are only very limited data looking into the effect of single-dose corticosteroids on SSI and wound healing. 26 Therefore, we decided to include a single-dose dexamethasone (or placebo) as another treatment factor, which was also assigned under factorial randomization. The current report is restricted to the hypercapnia vs normocapnia randomization.
Volatile anaesthetic administration was adjusted to maintain mean arterial pressure (MAP) at 90% of pre-induction value. Small boluses of phenylephrine (i.e. 50-100 mg) and fluid administration were also used as necessary. Intraoperative crystalloids were generally given at a rate of 6-10 ml kg 21 h 21 , which is considered as a relatively restrictive approach; 27 however, variations based on clinical judgement were permitted. Target minimum haematocrit (HCT) was determined before randomization based on the patient's age and cardiovascular status. The target HCT was 26% in patients aged ,65 yr having no significant cardiovascular disease and 28% in patients aged ≥65 yr or having cardiovascular disease. Significant cardiovascular disease was defined as history of myocardial infarction or peripheral vascular disease. HCT was maintained ≥30% in patients having both significant cardiovascular disease and age ≥65 yr. Intraoperative core temperature was maintained near 368C. Core temperature was maintained to the extent possible with upper body, forced-air covers. Fluids were warmed if necessary. Patients who were hypothermic (,368C) upon arrival in the post-anaesthesia care unit were warmed with a full body, forced-air cover.
Anaesthesiologists were not blinded to group assignments, but gas monitors were shielded to prevent surgeons from determining randomized group assignment. After giving the report to the post-anaesthesia care nurse, the anaesthesia record was sealed in an envelope as a part of the blinding process until patient's discharge (except at the University of Vienna and the Cleveland Clinic, which both used electronic records). Postoperative pain relief was maintained by patientcontrolled i.v. morphine or hydromorphone analgesia, or by epidural analgesia in patients who received epidural analgesia. Epidural catheters were most often inserted in the lumbar rather than thoracic region; local anaesthetic, epidural opioids, or both were only given after operation.
Attending surgeons, who were blinded to the randomized assignments, made hospital discharge decisions. Discharge timing was based on routine surgical considerations, including return of bowel function, control of infections (if any), adequate healing of the incision, and overall recovery during the postoperative period. Major complications including readmission, anastomotic leak, ileus, wound dehiscence, pneumonia, sepsis, and acute renal failure were monitored up to 30 days after operation (see Appendix 1).
The SSI outcome was monitored for up to 30 days. Patients were called on the 15th and 30th postoperative days for followup if they were not at the hospital or surgeon's clinic on those days. Patients were asked to return to their physician or to the hospital if their answers suggested they had an infection.
Measurements
Factors potentially influencing infection risk were recorded, including patient comorbidity, laboratory values, and anaesthetic and surgical management. End-tidal carbon dioxide (PE ′ CO 2 ) pressures were measured from the side-stream endtidal gas measurement unit of Datex-Ohmeda systems. Intraoperative haemodynamic values and PE ′ CO 2 were collected every 15 min, and these values were averaged for each patient. Patients were asked to rate their pain on a 10 cm visual analogue scale (VAS) during the first hour of recovery, and on the first postoperative morning. In the recovery period, pain VAS scores were recorded at 30 min intervals. On the first postoperative morning, patients were asked to provide a single VAS value that summarized their pain experience as leaving the recovery unit.
Infection risk was evaluated with the system from the Efficacy of Nosocomial Infection Control (SENIC) of the Centers for Disease Control and Prevention (CDC), which assigns one point for each of the following factors: three or more underlying diagnoses at discharge, surgery that lasts ≥2 h, an abdominal site of surgery, and the presence of a contaminated or infected wound. 28 As in previous studies, we modified the system by using the number of diagnoses at admission rather than at discharge. Although the SENIC score was established well before laparoscopic surgery became common, we designated patients having laparoscopic-assisted colectomies as having an abdominal surgical site. Infection risk was also evaluated with the National Nosocomial Infection Surveillance System, which predicts risk on the basis of the type of surgery, the rating of physical status on a scale developed by the ASA, and the duration of surgery. 29 SSI was defined by CDC criteria 30 and characterized as superficial incisional, deep incisional, or peritoneal. Wound healing was numerically scored using the ASEPSIS system. 31 This is an established and validated system for quantifying surgical wound infections and evaluating wound healing. The score is derived from the weighted sum of points assigned for the following factors: (i) duration of antibiotic administration; (ii) drainage of pus under local anaethesia; (iii) debridement of the wound under general anaethesia; (iv) serous discharge; (v) erythema; (vi) purulent exudate; (vii) separation of deep tissues; (viii) isolation of bacteria from discharge; and (ix) hospitalization exceeding 14 days.
Wounds were evaluated daily throughout hospitalization by an investigator blinded to treatment. Subsequently, patients were phoned on the 15th and 30th days and a scripted interview was used to inquire about SSI. When answers suggested that infection was likely, efforts were made to obtain relevant records. An investigator blinded to treatment adjudicated infections and complications using all available data.
Data analysis
Our primary outcome was the incidence of SSI within 30 days of surgery. Secondary outcomes included wound-healing scores, return of bowel function, and the duration of hospitalization. Values obtained at intervals throughout surgery were averaged in each patient, and then averaged among the patients in each group. Results were compared using t or x 2 tests, and nonparametric t-tests as appropriate. Gaussian distributions were used in deciding between parametric and non-parametric test selection with the exception of 'pain-VAS scores' and 'ASEPSIS', which were both planned as non-parametric tests a priori. Other outcome parameters analysed with non-parametric tests were first flatus, first food, first bowel movement, and duration of hospitalization.
Results are presented as means (SDs) and medians [interquartile ranges]; P,0.05 was considered statistically significant.
Results
For administrative reasons related to data entry and validation, the initial interim analysis, which was to be at 1000 patients, was delayed until 1139 patients were enrolled. Based on a futility analysis, the study was stopped by the Executive Committee. An additional 76 patients were enrolled while the committee evaluated the initial results; consequently, 1215 patients were enrolled when the study was stopped and 1206 included in final analysis. Nine patients were removed from the study by the attending anaethesiologist after randomization, because they did not find the patients suitable to the study. Therefore, no additional data were collected from these patients. Six study centres enrolled patients: University of Vienna (n¼369), Cleveland Clinic (n¼295), Washington University (n¼201), University of Louisville (n¼195), Mater Misericordiae University Hospital Dublin (n¼96), and University of Bern (n¼59). Figure 1 shows the trial profile diagram.
Clinical characteristics, diagnoses, surgical procedures, duration of surgery, haemodynamic values, and anaesthetic management were generally similar in patients randomized to each intervention (Table 1) . Prophylactic antibiotics were given 36 (40) min [mean (SD)] before the surgery started. Patients in the initial randomization (n¼629) and the factorial randomization (n¼586) were similar based on their patient characteristic, morphometrics, primary illnesses, type of surgery, and medical history.
Pa CO 2 was 5.2 (1.3) kPa in patients assigned to normocapnia and 7.1 (0.9) kPa in those assigned to hypercapnia. PE ′ CO 2 values, which were recorded every 15 min throughout surgery, were 4.7 (0.7) kPa and 6.3 (0.8) kPa, respectively. PE ′ CO 2 values corresponding to the randomized carbon dioxide levels are presented in Figure 2 to show compliance to randomization. The major reason clinicians obtained arterial blood analysis was to determine haemoglobin concentrations; Pa CO 2 values were thus available only in a subset of the study population (518 patients). In 72 of these patients ( 14%), at least one pH measurement was ,7.25. There were a total of 14 values of pH,7.20 of 518 (2.7%). All but 1 of the 14 values were in the hypercapnia group (5%).
Overall, SSI rates in the centres ranged from 8 to 20% (P¼0.098), but the rates were similar in each centre as a function of randomized treatments. There were also no significant differences among the treatment groups in ASEPSIS score, duration of hospitalization, major complications, or mortality. A total of 160 patients received epidural analgesia; their incidence of SSI was 10%. After accounting for randomized carbon dioxide management, there were no differences in SSI rates in patients who did and did not receive epidural analgesia (P¼0.48).
Major complications included readmission in 49 patients, electrolyte imbalance in 17, anastomotic leak in 12, ileus in 6, wound dehiscence in 6, pneumonia in 6, sepsis in 5, and acute renal failure in 5. The first postoperative bowel movement was about half a day earlier in the hypercapnia compared with the normocapnia group (P¼0.007, Table 2 ).
SSI developed in 11.2% of the 590 subjects who received hypercapnia and in 13.3% of the 616 who received normocapnia (two-tailed Fisher's exact test, P¼0.29). The relative risk [interim-adjusted 95% confidence interval (CI)] was 0.84 (0.57, 1.24), P¼0.24. The observed Z-statistic of 21.2 crossed neither the efficacy boundary (Z,22.5) nor the futility boundary (Z.20.238). However, the conditional power for finding a statistically significant difference if the study were to continue to completion with a similar trend was only 50%. If the study had continued with the hypercapnia and normocapnia groups having the same rate of SSI, 4168 patients would have been needed to reach an a (P) of 0.05 under 90% power. The Executive Committee thus stopped the trial.
As shown in Figure 3 , the SSI rate was associated with body mass index (BMI, P,0.01 multivariate). Surgical approach (laparoscopic-assisted vs open), ASA, and SENIC scores did not significantly influence the incidence of SSI. Overall mortality was too low to be considered within any comparison, and, more importantly, the study was not powered for this outcome.
Discussion
In this large multicentre randomized-controlled trial, we could not prove our hypothesis that mild hypercapnia reduces the incidence of SSI in colorectal resection surgery patients. The study was stopped by the Executive Committee at the interim analysis-without passing the futility boundarybecause the chances of a positive outcome were low even if the trial continued to the planned sample size of 2000. We considered an effect of 33% relative decrease in the SSI rate in our sample size estimate. Such relative difference represented a 2.8% absolute difference between the projected SSI rates, because our estimated SSI rates, which were used as base levels in our sample-size estimate, were relatively low (8.2 vs 5.4%) compared with the current rates of 11-13% or even higher previously published rates of 13-28%. 32 Our low SSI estimate represented the data from a large study we performed in colorectal surgery patients more than a decade ago. 1 In spite of the relatively large difference between the projected SSI rates and the current actual SSI frequency, our results showed an absolute difference of 2.1% between the study groups. Obviously, the observed 2.1% difference is not much different than the projected absolute difference of 2.8%. However, the relative difference is the parameter that drives the statistically significant difference and is, therefore, the essential component of sample-size estimates. The current difference of 2.1%, which converts to a relative difference of 15-16%, is less than half of the projected 33% relative difference (efficacy). On the other hand, our projected relative
Consented n=1215
Randomized n=1215
Hypercapnia n=592
Normocapnia n=623
Drop out n=2 Drop out n=7
Analysed n=616
Analysed n=590 difference of 33% (i.e. 33% reduction) is still within the 95% CI of the actual difference found (44% reduction to 24% increase). This means the observed treatment effect's CI ranged from a relative risk of 0.57 to 1.24, is consistent with a true treatment effect ranging from a 43% reduction to a 24% increase in infection rates. Therefore, this study cannot totally be considered as a study with no difference, and so there is the possibility of a Type II error. Although our results did neither cross the futility border nor report a strongly negative trial, we could not justify more than doubling our study patients compared with the projected sample-size because of limited funding. As a result, the Executive Committee decided to stop the trial prematurely at the time of initial interim analysis. Cardiac index increases 10 -15% for each 10 mm Hg increment in Pa CO 2 . 11 33 34 Increasing Pa CO 2 also shifts the oxyhaemoglobin dissociation curve rightward and decreases systemic vascular resistance, thereby improving tissue oxygen availability. 18 33 -35 That mild hypercapnia improves cardiac output, increases systemic oxygen delivery, and increases both peripheral subcutaneous tissue and splanchnic oxygenation are well established facts in animals, human volunteers, and patients. 14 18 33 -35 Improved oxygenation enhances surgical outcomes. 36 There was thus considerable reason to believe that mild-to-moderate hypercapnia would reduce the risk of SSI. Nonetheless, hypercapnia's effect was found much smaller than expected, and we therefore could not show a reduction in the incidence of SSI in our patients.
Continued
It is possible that a yet-to-be-detailed effect of hypercapnia in immune responses negated the putative benefits of improved tissue oxygenation. Hypercapnia may impair innate immunity or alter wound healing, especially during the perioperative period. 37 -39 However, the most likely explanations for our surprising finding are that either hypercapnia could not increase tissue oxygenation by 25-30 mm Hg as expected, 14 15 which was possibly attributable to a perfusion compromise that blunted the tissue oxygen delivery, or hypercapnia caused increased tissue oxygenation increase, but possibly the rate of oxygenation increase was insufficient to produce a clinically important reduction in infection risk in the specific setting tested. Because tissue oxygen tensions were not measured in this study, these explanations are only hypothetical.
In this study, we did not measure tissue oxygenation, because the relationship between Pa CO 2 and tissue oxygen partial pressure is well established. 11 33 34 However, there is still a chance that our intervention of application of mild hypercapnia did not alter tissue oxygenation at the same ratio we have shown before.
Another major factor influencing tissue oxygenation is arterial oxygen level itself. Similar ranges of inspired oxygen were applied in both study patient groups, and the resulting Pa O 2 values obtained were similar in patients in whom bloodgas analyses were done. Arterial blood gas measurements were not required by protocol, but the results were recorded when obtained for clinical reasons. In the light of our previous trials, the effects of FI O 2 on arterial oxygenation in the colorectal surgery setting were considered to be predictable. However, our current data proved this wrong, because Pa O 2 levels for the FI O 2 0.80 group were comparably lower than published previous trials. 1 40 One explanation for this is a possible selection bias. Because arterial blood-gas analysis was not enforced in the current trial, it is likely that the analysis was done in sicker patients with expected oxygenation problems.
After discharge, patients were followed up with standardized phone interviews. Patients were asked to return to their physician or to the hospital if their answers suggested they had an infection. Although post-discharge SSI was uncommon, partial reliance on phone interviews for a major study outcome was a limitation of our trial.
Prevalence of obesity has gradually increased in the population since the first study of supplemental oxygen and infection was published a decade ago. Obesity reduces tissue oxygenation. 17 41 42 It is also well established that obese patients experience more perioperative complications and increased SSI rates. 43 Our results extend previous findings by presenting a clear 'dose -response' type relationship between BMI and SSI. The infection rate was more than doubled in patients with a BMI .35 kg m 22 compared with patients with BMI 18-25 kg m 22 . Prevention measures, such as timely application of appropriate prophylactic antibiotics 44 and maintaining perioperative normothermia, 2 may thus be especially important in obese patients.
Laparoscopic colorectal surgery was shown to decrease SSI rate, 45 but this effect was not always consistent. 46 Laparoscopic colonic surgery significantly decreases tissue oxygenation early in the course of surgery. 47 As tissue oxygenation is one of the most important predictors of SSI, 8 48 inconsistency in results is unsurprising. Laparoscopic surgery was not an independent risk factor of SSI in our study.
The Executive Committee stopped the trial because the treatment effect appeared to be too small and unlikely to reach statistical significance even if the study was carried to completion. However, there was a slight apparent treatment effect, with infection rates of 11.2 and 13.3% in the hypercapnia and normocapnia groups, respectively. It thus remains possible that hypercapnia reduces the risk of SSI; but if it does, the effect appears to be small and could only be demonstrated by a very large trial.
In conclusion, it is well established that mild-to-moderate hypercapnia increases tissue PO 2 by roughly 25-30 mm Hg. However, the risk of SSI was not significantly reduced in 1206 patients randomized to mild hypercapnia (PE ′ CO 2 ¼50 mm Hg, n¼590, 11.2% SSI) compared with normocapnia (PE ′ CO 2 ¼35 mm Hg, n¼616, 13.3% SSI). Mild hypercapnia appears to have little or possibly no ability to prevent surgical wound infections in the colorectal surgery setting tested.
